WADDELL & REED FINANCIAL INC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 186 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
WADDELL & REED FINANCIAL INC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$8,988,000
-89.6%
400,000
-86.1%
0.02%
-89.6%
Q4 2017$86,768,000
-24.9%
2,881,692
-6.0%
0.19%
-25.3%
Q3 2017$115,506,000
+31.8%
3,066,264
-2.5%
0.26%
+33.2%
Q2 2017$87,670,000
-17.5%
3,143,411
+1.7%
0.19%
-14.6%
Q1 2017$106,302,000
+19.3%
3,091,977
+0.1%
0.23%
+15.9%
Q4 2016$89,117,000
+43.9%
3,090,065
+58.8%
0.20%
+52.3%
Q3 2016$61,915,000
+3.5%
1,946,416
+5.6%
0.13%
+1.6%
Q2 2016$59,818,000
+4.4%
1,842,817
-10.1%
0.13%
+16.7%
Q1 2016$57,306,000
-9.2%
2,049,547
+15.7%
0.11%
+5.9%
Q4 2015$63,145,000
-9.3%
1,771,253
-15.9%
0.10%
-10.5%
Q3 2015$69,609,000
-26.2%
2,104,904
-6.6%
0.11%
-15.6%
Q2 2015$94,337,000
+9.8%
2,252,556
-14.6%
0.14%
+13.4%
Q1 2015$85,922,000
+15.1%
2,636,471
+12.2%
0.12%
+15.5%
Q4 2014$74,637,000
+48.8%
2,350,749
+16.0%
0.10%
+49.3%
Q3 2014$50,166,000
+44.8%
2,026,124
+32.1%
0.07%
+35.3%
Q2 2014$34,642,000
+62.2%
1,533,496
+74.7%
0.05%
+59.4%
Q1 2014$21,355,000877,7100.03%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders